Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
about
Sequencing and analysis of a South Asian-Indian personal genomePractical aspects of NGS-based pathways analysis for personalized cancer science and medicineTranslating cancer genomes and transcriptomes for precision oncologyNext-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?High-throughput sequencing for biology and medicineExploring predisposition and treatment response--the promise of genomicsGenomic sequencing in cancerTeaching residents genomic pathology: a novel approach for new technologyStructural variation discovery in the cancer genome using next generation sequencing: computational solutions and perspectivesGenome sequencing and cancerAnnotating individual human genomesGenomics of acute myeloid leukemiaClinical tumor sequencing: opportunities and challenges for precision cancer medicineDevelopment and preliminary evaluation of an online educational video about whole-genome sequencing for research participants, patients, and the general publicCIViC databaseNext generation sequencing of acute myeloid leukemia: influencing prognosis.Identification of targetable FGFR gene fusions in diverse cancers.Activating ESR1 mutations in hormone-resistant metastatic breast cancer.Organizing knowledge to enable personalization of medicine in cancerThe origin and evolution of mutations in acute myeloid leukemiaCharacterizing complex structural variation in germline and somatic genomesIdentification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairsDetection of structural DNA variation from next generation sequencing data: a review of informatic approaches.Genomic sequencing: assessing the health care system, policy, and big-data implications.Precision medicine in the age of big data: The present and future role of large-scale unbiased sequencing in drug discovery and development.Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing.Acute promyelocytic leukemia with a cryptic insertion of RARA into PML on chromosome 15 due to uniparental isodisomy: A case report.Detection of gene rearrangements in targeted clinical next-generation sequencing.The changing mutational landscape of acute myeloid leukemia and myelodysplastic syndrome.Progress and potential: training in genomic pathologyPersonalized oncology through integrative high-throughput sequencing: a pilot study.Next-generation sequencing for cancer diagnostics: a practical perspective.Applying next-generation sequencing to pancreatic cancer treatment.Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and processValue of oligonucleotide-based array comparative genomic hybridization for diagnosis of acute promyelocytic leukemia in a patient negative for t(15;17)(q24.1;q21.2)/promyelocytic leukemia-retinoic acid receptor, alpha by conventional cytogenetics anChallenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.Direct-to-consumer personalized genomic testing.Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.Oncolytic virotherapy for hematological malignancies.Translating cancer 'omics' to improved outcomes.
P2860
Q21266697-7E25B37F-24C6-4349-9BE4-993DFCDB22A1Q26748603-F57CF12D-7008-4F1A-A42A-4ECE02D00238Q26777081-E6ED0513-3DA0-41D9-BE0E-3111716FFEFEQ26781271-EDA0793A-099A-4282-9857-102392DE81AEQ26823498-1F15DA52-532B-46CC-AF02-86588AA343F4Q26851609-4902C796-E604-45C5-AFCA-30FD10BCD3CDQ26853507-87F21E7D-8093-4942-8407-A0CBA23D3B61Q26859129-B82C7492-7B02-4875-BE82-A749835D2EFEQ26991436-B956EE33-1194-46F5-9BC5-7581AA53CDAEQ26998499-61CD7CFA-ED27-4E50-83A6-3CD7E07EF8E0Q26999723-FBB1978F-B547-4175-95D2-44DFB82695B6Q27021548-3B1EB7D2-A5C1-4F47-9F89-CCE93084831AQ27027942-D7F3268F-8D2F-46BB-9073-CD7B48A1DBE9Q27324190-AEB310F7-5FD9-42DD-B840-8551A7AD5D13Q27612411-D98917E5-D17C-4B72-9B4A-F04FEA4F84CEQ27690776-6AA82C6C-CB50-4423-822B-91BE687754B7Q27852147-3293487E-D804-4207-B80F-203D0E42E1CBQ27852630-02C3A657-4981-424E-98BF-02DA5838C084Q28652806-79372CC3-1B22-48BA-B57F-67A8CCCF0A09Q29614630-F195E486-048D-4D2F-9266-CCE4EECB4E1EQ30423222-CF091BB6-6BCA-4A0C-A5A6-94DE96CF30E5Q30543431-6265D123-F0AB-4CCF-B4DC-891018B39B67Q30729747-8798B3E7-4789-41B8-A243-15453D2BF972Q30835712-FC045905-E136-4814-A59B-331D4168BC50Q31017820-077A5532-4DD8-4826-82D3-FEF5787B023AQ33405269-2F379AF4-6884-498A-A3DF-87677C1D41DAQ33751316-1C70B733-F1F6-4BF2-80C6-11B7C80D62C6Q33833183-26F6090C-3DAF-4688-A85E-312920EADC14Q34010735-819D6E1F-6DDC-48C1-907E-4789F73F333CQ34117277-44FAE424-843B-4792-80C1-D6BE76B62A1EQ34237470-476C8415-A883-48B3-9D7C-586BB9AD55C7Q34238930-31E076E9-9B1E-4B73-821F-CB1B5966DB0AQ34285351-FD077B84-4023-4305-9FF0-816F50040DD4Q34549035-4141D563-F458-453E-8B5C-1B19F472C5BAQ34652091-993B8FB7-EA71-47C3-8090-B23416C5374AQ35213023-D643A3FB-70AB-4955-9D4B-90E53B706162Q35230171-51C6E608-1AA4-4AF0-84A6-3C8B91ECBE4FQ35636877-2436FD4C-5732-4768-82BD-513AF80A3644Q35692095-FE75F1A5-4F39-4607-A7DB-CAC9362DFC53Q35694365-1EB176A8-B432-4DAD-BBFF-E7810494B7B9
P2860
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
@ast
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
@en
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
@nl
type
label
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
@ast
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
@en
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
@nl
altLabel
Use of Whole-Genome Sequencing to Diagnose a Cryptic Fusion Oncogene
@en
prefLabel
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
@ast
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
@en
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
@nl
P2093
P2860
P3181
P356
P1476
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
@en
P2093
Daniel C Link
David E Larson
Heather Schmidt
Jacqueline E Payton
Jeffery M Klco
Joelle Veizer
John F DiPersio
John S Welch
John Wallis
P2860
P304
P3181
P356
10.1001/JAMA.2011.497
P407
P577
2011-04-20T00:00:00Z